Shanghai RAAS Blood Products Co., Ltd. Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd.

002252

Rank in Stocks #3629
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.70862889
Market Cap
$4.67B
Change (1 day)
0.62%
Change (1 year)
-24.17%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)

Category

Healthcare
Dividend history for Shanghai RAAS Blood Products Co., Ltd. (002252)
Shanghai RAAS Blood Products Co., Ltd. (stock symbol: 002252) made a total of 18 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.47
Dividend yield (TTM) : 0.0097
Dividend payments for Shanghai RAAS Blood Products Co., Ltd. (002252) from 2009 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $0.0153 -53.64%
2025 $0.033 -50.75%
2024 $0.067 123.33%
2023 $0.03 7.14%
2022 $0.028 12.00%
2021 $0.025 150.00%
2020 $0.01 -41.18%
2018 $0.017 -43.33%
2017 $0.03 7.91%
2016 $0.0278 0.00%
2015 $0.0278 100.00%
2014 $0.0139 101.45%
2013 $0.0069 -82.12%
2012 $0.0386 24.92%
2011 $0.0309 -9.12%
2010 $0.034 -6.34%
2009 $0.0363 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.0153 -53.64%
2025 $0.033 -50.75%
2024 $0.067 123.33%
2023 $0.03 7.14%
2022 $0.028 12.00%
2021 $0.025 150.00%
2020 $0.01 -41.18%
2018 $0.017 -43.33%
2017 $0.03 -40.00%
2016 $0.05 -50.00%
2015 $0.1 0.00%
2014 $0.1 100.00%
2013 $0.05 -90.00%
2012 $0.5 25.00%
2011 $0.4 -46.67%
2010 $0.75 -6.25%
2009 $0.8 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
US
64.00%
AU
0.00%
CH
0.00%
NL